StreetAlpha.app
Home › Stocks › FEMY

Femasys Inc (FEMY)

$1.14
▼ −10.94%
LAST CLOSE · NOV 17

Femasys makes women's health devices and diagnostics for fertility and permanent birth control, sold mainly to gynecologists and clinics. It last closed at $1.14 on Nov 17, down 10.94% on the day.

AI Auto Pilots
Is FEMY in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.0M
−4.2% vs a year ago
Net income
−$12.1M
−614.7% margin
Free cash flow
−$17.3M
−877.5% margin
Gross margin
59.9%
$1.2M gross profit
Valuation
Market cap
$9.9M
8.7M shares
P/E
–
Price to sales
5.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$23.9M
At Sep 30
Shareholder equity
$27.0M
Shares outstanding
8.7M
At Nov 12
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.2M$1.2MFY2021FY2022: $1.2M$1.2MFY2022FY2023: $1.1M$1.1MFY2023FY2024: $1.6M$1.6MFY2024FY2025: $2.3M$2.3MFY2025

From FEMY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 13). Last 12 months adds up the four latest quarters.

Last report
Nov 13
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated FEMY in the past 90 days.
Average 12-month target
No price targets on FEMY in the past 90 days.
Latest rating changes
Lake StreetMaintained
Aug 18Buy$10
Maxim GroupMaintained
Aug 14Buy$10
DateFirmActionRatingPrice target
Aug 18Lake StreetMaintainedBuy$10
Aug 14Maxim GroupMaintainedBuy$10
Loading…

Technical Analysis

FEMY · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 23% below its 20 day and 66% below its 50 day average. It is 381% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 31), near oversold. The nearest support is the 52 week low at $1.07, and the nearest resistance the Pivot at $1.17.

Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 14.0%/day
Key levels
$20.8052 week high+1724.6%
$5.49200 day average+381.6%
$2.53100 day average+121.9%
$1.8950 day average+65.8%
$1.55Swing high (Nov 12)+36.0%
$1.4020 day average+22.8%
$1.26Pivot R1+10.5%
$1.17Pivot+2.6%
$1.14Last close
$1.0752 week low−6.1%
$1.04Pivot S1−8.8%
Indicators
RSI (14)31.12Weak, oversold below 30Neutral
MACD-0.16Above its signal lineBullish
Stochastic28.0Middle of its rangeNeutral
ADX (14)52.7Strong downtrend
Williams %R-85.4Oversold below −80, overbought above −20Oversold
CCI (20)-227.1Oversold below −100, overbought above 100Oversold
Rate of change−16.8%Change over 10 sessionsBearish
ATR (14)$0.16Typical daily range, 14.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for FEMY

What happened before

See how FEMY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow FEMY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How FEMY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in FEMY in the last 90 days.

Loading…

See today’s whale options flow across the market →

FEMY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲16 buying vs 9 selling
  • ▲Held by funds +52.0 pts
  • ▲Funds holding +8
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2820+40.0%
In funds' top 10110.0%
Held by funds75.9%23.9%+52.0 pts
New / increased12 / 418 / 0−11.1%
Reduced / sold out5 / 41 / 34−74.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FEMY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FEMY is in one of them and how their past FEMY trades turned out.

FEMY in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FEMY in an article yet. Here's the latest on the wider market.

About Femasys

Femasys is a women's health company based in Suwanee, Georgia, that makes medical devices and diagnostic products. Its fertility products include FemaSeed, a treatment that places sperm directly into the fallopian tube, along with FemSperm sperm preparation kits and FemVue, an ultrasound test of the fallopian tubes. It also offers FemBloc, a permanent birth control option that does not require surgery, along with the FemChec and FemCath products. Its customers are gynecologists, fertility clinics and other healthcare practitioners who treat women and couples.

Headquarters
Suwanee, GA